Under optimal conditions, immune surveillance permits recognition of tumor antigens, prompting T-cell-mediated elimination of tumor cells, a process that is critically dependent on HLA (also known as major histocompatibility complex, MHC) as described below. The gene discussed is HLA-C; the disease is neoplasm.